메뉴 건너뛰기




Volumn 8, Issue 10, 2007, Pages 1565-1573

Pimecrolinus versus topical corticosteroids in dermatology

Author keywords

Corticosteroid; Pimecrolimus; Randomised clinical trial

Indexed keywords

ASCOMYCIN; AZATHIOPRINE; BETAMETHASONE VALERATE; CALCIPOTRIOL; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOSPORIN A; HYDROCORTISONE; HYDROCORTISONE ACETATE; MOMETASONE FUROATE; PIMECROLIMUS; PREDNISOLONE; TACROLIMUS; TRIAMCINOLONE ACETONIDE; ANTIINFLAMMATORY AGENT; DERMATOLOGICAL AGENT; DRUG DERIVATIVE;

EID: 34447505927     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.8.10.1565     Document Type: Article
Times cited : (8)

References (33)
  • 2
    • 1542400364 scopus 로고    scopus 로고
    • Pimecrolimus for the treatment of inflammatory skin disease
    • WOLFF K, STUETZ A: Pimecrolimus for the treatment of inflammatory skin disease. Expert Opin. Pharmacother. (2004) 5(3):643-655.
    • (2004) Expert Opin. Pharmacother , vol.5 , Issue.3 , pp. 643-655
    • WOLFF, K.1    STUETZ, A.2
  • 3
    • 14844315610 scopus 로고    scopus 로고
    • Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: Meta-analysis of randomised controlled trials
    • ASHCROFT DM, DIMMOCK P, GARSIDE R, STEIN K, WILLIAMS HC: Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ. (2005) 330:516.
    • (2005) BMJ , vol.330 , pp. 516
    • ASHCROFT, D.M.1    DIMMOCK, P.2    GARSIDE, R.3    STEIN, K.4    WILLIAMS, H.C.5
  • 4
    • 33749361700 scopus 로고    scopus 로고
    • Topical pimecrolimus for skin disease other than atopic dermatitis
    • WOLLINA U, HANSEL G, KOCH A, ABDEL-NASER MB: Topical pimecrolimus for skin disease other than atopic dermatitis. Expert Opin. Pharmacother. (2006) 7(14):1967-1975.
    • (2006) Expert Opin. Pharmacother , vol.7 , Issue.14 , pp. 1967-1975
    • WOLLINA, U.1    HANSEL, G.2    KOCH, A.3    ABDEL-NASER, M.B.4
  • 5
    • 0000581086 scopus 로고
    • The effect of topically applied compound F in selected dermatoses
    • SULZBERGER MB, WITTEN VH: The effect of topically applied compound F in selected dermatoses. J. Invest. Dermatol. (1952) 19(2):101-102.
    • (1952) J. Invest. Dermatol , vol.19 , Issue.2 , pp. 101-102
    • SULZBERGER, M.B.1    WITTEN, V.H.2
  • 6
    • 0032406844 scopus 로고    scopus 로고
    • The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion
    • MROWIETZ U, GRAEBER M, BRAUTIGAM M et al.: The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion. Br. J. Dermatol. (1998) 139:992-996.
    • (1998) Br. J. Dermatol , vol.139 , pp. 992-996
    • MROWIETZ, U.1    GRAEBER, M.2    BRAUTIGAM, M.3
  • 7
    • 17744379151 scopus 로고    scopus 로고
    • SDZ ASM 981: An emerging safe and effective treatment for aropic dermatitis
    • LUGER T, VAN LEENT EJM, GRAEBER M et al.: SDZ ASM 981: an emerging safe and effective treatment for aropic dermatitis. Br. J. Dermatol. (2001) 144:788-794.
    • (2001) Br. J. Dermatol , vol.144 , pp. 788-794
    • LUGER, T.1    VAN LEENT, E.J.M.2    GRAEBER, M.3
  • 8
    • 0142025275 scopus 로고    scopus 로고
    • An experimental ointment formulation of pimecrolimus is effective in psoriasis without occlusion
    • MROWIETZ U, WUSTLICH S, HOEXTER G, GRAEBER M, BRAUTIGAM M, LUGER T: An experimental ointment formulation of pimecrolimus is effective in psoriasis without occlusion. Acta. Derm. Venereol. (2003) 83(5):351-353.
    • (2003) Acta. Derm. Venereol , vol.83 , Issue.5 , pp. 351-353
    • MROWIETZ, U.1    WUSTLICH, S.2    HOEXTER, G.3    GRAEBER, M.4    BRAUTIGAM, M.5    LUGER, T.6
  • 9
    • 9644257237 scopus 로고    scopus 로고
    • Pimecrolimus cream 1% versus betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial
    • RIGOPOULOS D, IOANNIDES D, KALOGEROMITROS D, GREGORIOU S, KATSAMBAS A. Pimecrolimus cream 1% versus betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial. Br. J. Dermatol. (2004) 151:1071-1075.
    • (2004) Br. J. Dermatol , vol.151 , pp. 1071-1075
    • RIGOPOULOS, D.1    IOANNIDES, D.2    KALOGEROMITROS, D.3    GREGORIOU, S.4    KATSAMBAS, A.5
  • 10
    • 3343004623 scopus 로고    scopus 로고
    • Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis
    • LUGER TA, LAHFA M, FOLSTER-HOLST R et al.: Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis. J. Dermatolog. Treat. (2004) 15:169-178.
    • (2004) J. Dermatolog. Treat , vol.15 , pp. 169-178
    • LUGER, T.A.1    LAHFA, M.2    FOLSTER-HOLST, R.3
  • 11
    • 15944426416 scopus 로고    scopus 로고
    • Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo
    • COSKUN B, SARAL Y, TURGUT D: Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo. Eur. J. Dermatol. (2005) 15(2):88-91.
    • (2005) Eur. J. Dermatol , vol.15 , Issue.2 , pp. 88-91
    • COSKUN, B.1    SARAL, Y.2    TURGUT, D.3
  • 12
    • 33747605048 scopus 로고    scopus 로고
    • Pimecrolimus cream, 1%, versus hydrocortisone acetate cream, 1%, in the treatment official seborrheic dermatitis: A randomized, investigator-blind, clinical trial
    • FIROOZ A, SOLHPOUR A, GOROUHI F et al.: Pimecrolimus cream, 1%, versus hydrocortisone acetate cream, 1%, in the treatment official seborrheic dermatitis: a randomized, investigator-blind, clinical trial. Arch. Dermatol. (2006) 142(8):1066-1067.
    • (2006) Arch. Dermatol , vol.142 , Issue.8 , pp. 1066-1067
    • FIROOZ, A.1    SOLHPOUR, A.2    GOROUHI, F.3
  • 13
    • 33748785967 scopus 로고    scopus 로고
    • 1% Pimecrolimus, 0.005% calcipotriol and 0.1% betamethasone in the treatment of intertriginous psoriasis: A double-blind, randomized controlled study
    • KREUTER A, SOMMER A, HYUN J et al.: 1% Pimecrolimus, 0.005% calcipotriol and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study. Arch. Dermatol. (2006) 142(9):1138-1143.
    • (2006) Arch. Dermatol , vol.142 , Issue.9 , pp. 1138-1143
    • KREUTER, A.1    SOMMER, A.2    HYUN, J.3
  • 15
    • 0041825562 scopus 로고    scopus 로고
    • Pimecrolimus does not affect the differentiation, maturation and function of human monocyte-derived dendritic cells, in contrast to corricosteroids
    • KALTHOFF ES, CHUNG J, MUSSER P, STUETZ A: Pimecrolimus does not affect the differentiation, maturation and function of human monocyte-derived dendritic cells, in contrast to corricosteroids. Clin. Exp. Immunol. (2003) 133:350-359.
    • (2003) Clin. Exp. Immunol , vol.133 , pp. 350-359
    • KALTHOFF, E.S.1    CHUNG, J.2    MUSSER, P.3    STUETZ, A.4
  • 16
    • 1842639441 scopus 로고    scopus 로고
    • Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells
    • HOETZENECKER W, MEINGASSNER JG, ECKER R, STINGL G, STUETZ A, ELBE-BÜRGER A: Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells. J. Invest. Dermatol. (2004) 122:673-684.
    • (2004) J. Invest. Dermatol , vol.122 , pp. 673-684
    • HOETZENECKER, W.1    MEINGASSNER, J.G.2    ECKER, R.3    STINGL, G.4    STUETZ, A.5    ELBE-BÜRGER, A.6
  • 17
    • 20444457467 scopus 로고    scopus 로고
    • Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis
    • HOETZENECKER W, ECKER R, STUETZ A, STINGL G, ELBE-BÜRGER A: Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis. J. Allergy Clin. Immunol. (2005) 115:1276-1283.
    • (2005) J. Allergy Clin. Immunol , vol.115 , pp. 1276-1283
    • HOETZENECKER, W.1    ECKER, R.2    STUETZ, A.3    STINGL, G.4    ELBE-BÜRGER, A.5
  • 18
    • 33644878417 scopus 로고    scopus 로고
    • Effect of pimecrolimus versus corticosteroids on murine bone marrow-derived dendritic cell differentiation, maturation and function
    • KRUMMEN MBW, VARGA G, STEINERT M, STUETZ A, LUGER TA, GRABBE S: Effect of pimecrolimus versus corticosteroids on murine bone marrow-derived dendritic cell differentiation, maturation and function. Exp. Dermatol. (2006) 15(1):43-50.
    • (2006) Exp. Dermatol , vol.15 , Issue.1 , pp. 43-50
    • KRUMMEN, M.B.W.1    VARGA, G.2    STEINERT, M.3    STUETZ, A.4    LUGER, T.A.5    GRABBE, S.6
  • 19
    • 33747378525 scopus 로고    scopus 로고
    • Both pimecrolimus and corticosteroids deplete plasmatocytoid dendritic cells in patients with atopic dermatitis
    • HOETZENECKER W, MEINDL S, STUETZ A, STINGL G, ELBE-BORGERA. Both pimecrolimus and corticosteroids deplete plasmatocytoid dendritic cells in patients with atopic dermatitis. J. Invest. Dermatol. (2006) 126:2141-2144.
    • (2006) J. Invest. Dermatol , vol.126 , pp. 2141-2144
    • HOETZENECKER, W.1    MEINDL, S.2    STUETZ, A.3    STINGL, G.4    ELBE-BORGERA5
  • 20
    • 0037464506 scopus 로고    scopus 로고
    • Skin cancers after organ transplantation
    • EUVRARD, S, KANITAKIS J, CLAUDY A: Skin cancers after organ transplantation. N. Engl. J. Med. (2003) 348:1681-1691.
    • (2003) N. Engl. J. Med , vol.348 , pp. 1681-1691
    • EUVRARD, S.1    KANITAKIS, J.2    CLAUDY, A.3
  • 21
    • 32844468634 scopus 로고    scopus 로고
    • Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation
    • YAROSH D, PENA AV, NAY SL, CANNING MT, BROWN DA: Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation. J. Invest. Dermatol. (2005) 125:1020-1025.
    • (2005) J. Invest. Dermatol , vol.125 , pp. 1020-1025
    • YAROSH, D.1    PENA, A.V.2    NAY, S.L.3    CANNING, M.T.4    BROWN, D.A.5
  • 22
    • 33751303107 scopus 로고    scopus 로고
    • Calcineurin inhibitors reduce nuclear localization of transcription factor NFAT in UV-irradiated keratinocytes and reduce DNA repair
    • CANNING MT, NAY SL, PENA AV, YAROSH DB: Calcineurin inhibitors reduce nuclear localization of transcription factor NFAT in UV-irradiated keratinocytes and reduce DNA repair. J. Mol. Hist. (2006) 37:285-291.
    • (2006) J. Mol. Hist , vol.37 , pp. 285-291
    • CANNING, M.T.1    NAY, S.L.2    PENA, A.V.3    YAROSH, D.B.4
  • 23
    • 33745245725 scopus 로고    scopus 로고
    • Production and clearance of cyclobutane dipyrimidine dimers in UV-irradiated skin pretreated with 1% pimecrolimus or 0.1% triamcinolone acetonide creams in normal and atopic patients
    • DOELKER L, TRAN C, GKOMOUZAS A et al.: Production and clearance of cyclobutane dipyrimidine dimers in UV-irradiated skin pretreated with 1% pimecrolimus or 0.1% triamcinolone acetonide creams in normal and atopic patients. Exp. Dermatol. (2006) 15(5):342-346.
    • (2006) Exp. Dermatol , vol.15 , Issue.5 , pp. 342-346
    • DOELKER, L.1    TRAN, C.2    GKOMOUZAS, A.3
  • 24
    • 33646557042 scopus 로고    scopus 로고
    • A cost-utility analysis of pimecrolimus versus topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema
    • PITT M, GARSIDE R, STEIN K: A cost-utility analysis of pimecrolimus versus topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema. Br. J. Dermatol. (2006) 154:1137-1146.
    • (2006) Br. J. Dermatol , vol.154 , pp. 1137-1146
    • PITT, M.1    GARSIDE, R.2    STEIN, K.3
  • 25
    • 33744727361 scopus 로고    scopus 로고
    • Pimecrolimus cream 1% is effective in seborrhoeic dermatitis refractory to treatment with topical corticosteroids
    • CUNHA PR: Pimecrolimus cream 1% is effective in seborrhoeic dermatitis refractory to treatment with topical corticosteroids. Acta. Derm. Venereol. (2006) 86(1):69-70.
    • (2006) Acta. Derm. Venereol , vol.86 , Issue.1 , pp. 69-70
    • CUNHA, P.R.1
  • 26
    • 0142258867 scopus 로고    scopus 로고
    • Repigmentation of vitiligo with pimecrolimus cream: A case report
    • MAYORAL FA, GONZALEZ C, SHAH NS, ARCINIEGAS C: Repigmentation of vitiligo with pimecrolimus cream: a case report. Dermatology (2003) 207(3):322-323.
    • (2003) Dermatology , vol.207 , Issue.3 , pp. 322-323
    • MAYORAL, F.A.1    GONZALEZ, C.2    SHAH, N.S.3    ARCINIEGAS, C.4
  • 27
    • 8744304117 scopus 로고    scopus 로고
    • Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: A double-blind, randomized study
    • GRIBETZ C, LING M, LEBWOHL M et al.: Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study. J. Am. Acad. Dermatol. (2004) 51(5):731-738.
    • (2004) J. Am. Acad. Dermatol , vol.51 , Issue.5 , pp. 731-738
    • GRIBETZ, C.1    LING, M.2    LEBWOHL, M.3
  • 28
    • 0035081866 scopus 로고    scopus 로고
    • The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: A randomized, double-blind controlled study
    • QUEILLE-ROUSSEL C, PAUL C, DUTEIL L et al.: The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. Br. J Dermatol. (2001) 144:507-513.
    • (2001) Br. J Dermatol , vol.144 , pp. 507-513
    • QUEILLE-ROUSSEL, C.1    PAUL, C.2    DUTEIL, L.3
  • 29
    • 0036677154 scopus 로고    scopus 로고
    • Long-term management of atopic dermatitis in infants with topical pimecrolimus, a non-steroid anti-inflammatory drug
    • KAPP A, PAPP K, BINGHAM A et al.: Long-term management of atopic dermatitis in infants with topical pimecrolimus, a non-steroid anti-inflammatory drug. J. Allergy Clin. Immunol. (2002) 110:277-284.
    • (2002) J. Allergy Clin. Immunol , vol.110 , pp. 277-284
    • KAPP, A.1    PAPP, K.2    BINGHAM, A.3
  • 30
    • 0036634394 scopus 로고    scopus 로고
    • Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children
    • VAHN U, BOS JD, GOODFIELD M et al.: Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics (2002) 110:e2.
    • (2002) Pediatrics , vol.110
    • VAHN, U.1    BOS, J.D.2    GOODFIELD, M.3
  • 31
    • 10744225363 scopus 로고    scopus 로고
    • Pimecrolimus cream 1%: A potential new treatment for chronic hand dermatitis
    • BELSITO DV, FOWLER JF Jr, MARKS JG Jr et al.: Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis. Cutis (2004) 73:31-38.
    • (2004) Cutis , vol.73 , pp. 31-38
    • BELSITO, D.V.1    FOWLER Jr, J.F.2    MARKS Jr, J.G.3
  • 32
    • 17844383944 scopus 로고    scopus 로고
    • Randomized controlled trial of pimecrolimus 1% cream for treatment facial acne vulgaris
    • TAN JKL, MORNEAU K, FUNG K: Randomized controlled trial of pimecrolimus 1% cream for treatment facial acne vulgaris. J. Am. Acad. Dermatol. (2005) 52:738-739.
    • (2005) J. Am. Acad. Dermatol , vol.52 , pp. 738-739
    • TAN, J.K.L.1    MORNEAU, K.2    FUNG, K.3
  • 33
    • 24144433476 scopus 로고    scopus 로고
    • Topical pimecrolimus in the treatment of genital lichen planus: A prospective case series
    • LONSDALE-ECCLES AA, VELANGI S: Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series. Br. J. Dermatol. (2005) 153:390-394.
    • (2005) Br. J. Dermatol , vol.153 , pp. 390-394
    • LONSDALE-ECCLES, A.A.1    VELANGI, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.